CN1795001A - 内用药物,更具体为用于治疗癌症的内用药物 - Google Patents

内用药物,更具体为用于治疗癌症的内用药物 Download PDF

Info

Publication number
CN1795001A
CN1795001A CNA2004800140406A CN200480014040A CN1795001A CN 1795001 A CN1795001 A CN 1795001A CN A2004800140406 A CNA2004800140406 A CN A2004800140406A CN 200480014040 A CN200480014040 A CN 200480014040A CN 1795001 A CN1795001 A CN 1795001A
Authority
CN
China
Prior art keywords
weight
specifically
surfactant
medicine
polydimethylsiloxane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800140406A
Other languages
English (en)
Chinese (zh)
Inventor
G·特内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1795001A publication Critical patent/CN1795001A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CNA2004800140406A 2003-05-22 2004-05-19 内用药物,更具体为用于治疗癌症的内用药物 Pending CN1795001A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10323758.5 2003-05-22
DE10323758A DE10323758A1 (de) 2003-05-22 2003-05-22 Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen

Publications (1)

Publication Number Publication Date
CN1795001A true CN1795001A (zh) 2006-06-28

Family

ID=33441299

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800140406A Pending CN1795001A (zh) 2003-05-22 2004-05-19 内用药物,更具体为用于治疗癌症的内用药物

Country Status (9)

Country Link
US (1) US20070172435A1 (https=)
EP (1) EP1635849A1 (https=)
JP (1) JP2006528211A (https=)
CN (1) CN1795001A (https=)
AU (1) AU2004243524A1 (https=)
CA (1) CA2526175A1 (https=)
DE (1) DE10323758A1 (https=)
RU (1) RU2005140097A (https=)
WO (1) WO2004105776A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104606261A (zh) * 2015-03-05 2015-05-13 潘友长 一种沸石药物组合物及其制备方法和用途
CN105837734A (zh) * 2016-05-09 2016-08-10 上海惠昌化工厂 有机硅改性丙烯酸聚酯钾盐及制备方法和防癌治癌用途

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10323759A1 (de) * 2003-05-22 2004-12-16 Bauer, Wulf, Dr. Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen
DE102007043748A1 (de) 2007-09-13 2008-09-11 Basf Se Verfahren zur kontinuierlichen Abtrennung eines Zielproduktes X in Form von feinteiligem Kristallisat
DE102007043759A1 (de) 2007-09-13 2008-09-11 Basf Se Verfahren zum Betreiben einer kontinuierlichen Abtrennung eines Zielproduktes X in Form von feinteiligem Kristallisat
BE1018537A3 (fr) 2007-09-13 2011-03-01 Basf Se Procede d'exploitation d'une separation en continu d'un produit cible x sous la forme d'un cristallisat finement divise.
DE102007043758A1 (de) 2007-09-13 2008-10-23 Basf Se Verfahren zum Betreiben einer kontinuierlichen Abtrennung eines Zielproduktes X in Form von feinteiligem Kristallisat des Zielproduktes X
DE102009045767A1 (de) 2009-10-16 2010-08-12 Basf Se Verfahren der Inbetriebnahme eines Trennverfahrens zur reinigenden Abtrennung von Acrylsäurekristallen aus einer Suspension S ihrer Kristalle in Mutterlauge
DE102010030279A1 (de) 2010-06-18 2010-10-28 Basf Se Verfahren der Inbetriebnahme eines Trennverfahrens zur reinigenden Abtrennung von Acrylsäurekristallen aus einer Suspension S ihrer Kristalle in Mutterlauge
US8461383B2 (en) 2009-10-16 2013-06-11 Basf Se Process for starting up a separating process for purifying removal of acrylic acid crystals from a suspension S of crystals thereof in mother liquor
EP3223828B1 (en) * 2014-11-24 2020-06-17 University Of Technology, Sydney Methods for the treatment and prevention of asbestos-related diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310572A (en) * 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
US5418220A (en) * 1994-03-08 1995-05-23 Schmidt; Alfred Method for treating constipation using dimethicone
US5587149A (en) * 1995-02-06 1996-12-24 R.P. Scherer Corporation Topical application emulsions
DE19780248D2 (de) * 1996-03-25 1999-03-11 Bauer Wulf Dr Heilmittel zur äußerlichen Anwendung und Verwendung einer wässrigen Öl-Emulsion für ein derartiges Heilmittel
US6347408B1 (en) * 1998-11-05 2002-02-19 Allegiance Corporation Powder-free gloves having a coating containing cross-linked polyurethane and silicone and method of making the same
EP1316530B1 (de) * 1999-04-26 2004-12-15 Tihomir Lelas Mikronisierte Zoelithe zur Verwendung als pharmazeutisches Mittel

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104606261A (zh) * 2015-03-05 2015-05-13 潘友长 一种沸石药物组合物及其制备方法和用途
CN104606261B (zh) * 2015-03-05 2018-02-09 潘友长 一种沸石药物组合物及其制备方法和用途
CN105837734A (zh) * 2016-05-09 2016-08-10 上海惠昌化工厂 有机硅改性丙烯酸聚酯钾盐及制备方法和防癌治癌用途

Also Published As

Publication number Publication date
RU2005140097A (ru) 2006-08-10
JP2006528211A (ja) 2006-12-14
CA2526175A1 (en) 2004-12-09
DE10323758A1 (de) 2004-12-16
WO2004105776A1 (de) 2004-12-09
EP1635849A1 (de) 2006-03-22
AU2004243524A1 (en) 2004-12-09
US20070172435A1 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
Yang et al. Drug–clay nanohybrids as sustained delivery systems
CN1795001A (zh) 内用药物,更具体为用于治疗癌症的内用药物
Zhang et al. Synthesis and characterization of methacrylate-functionalized betulin derivatives as antibacterial comonomer for dental restorative resins
Sivamaruthi et al. Mesoporous silica-based nanoplatforms are theranostic agents for the treatment of inflammatory disorders
JP2009506076A5 (https=)
CN1313756A (zh) 口服液体的粘膜粘附组合物
Krajišnik et al. Chitosan–clay mineral nanocomposites with antibacterial activity for biomedical application: advantages and future perspectives
EP4582147A2 (en) Treatment of hyperinflammatory syndrome
WO2002055088A1 (en) Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents
EP4255391B1 (en) Luminol for use in the treatment of sequelae of a sars-cov-2 infection
Zeng et al. Emerging trends in the application of extracellular vesicles as novel oral delivery vehicles for therapeutics in inflammatory diseases
CN1795002A (zh) 用于治疗癌症的基于岩石粉、更具体是白云石粉的药物
JP2006528211A5 (https=)
CN101040872A (zh) 蒙脱石干混悬剂及制备方法
US2951011A (en) Silicone composition for the relief of gastro-intestinal distress and method of using same
CN1302780C (zh) 烷基胆碱磷酸在制备用抗肿瘤药之前和/或期间治疗肿瘤的药物中的应用
Hodgson et al. Saunders Nursing Drug Handbook 2013
JP2006528210A5 (https=)
Xia et al. Preparation and in vitro antitumor study of two-dimensional muscovite nanosheets
CN116940351A (zh) 前药组合物和治疗方法
Jain et al. Naturally occuring clay, montmorillonite, as a drug delivery vehicle for in vitro extended release of venlafaxine hydrochloride
CN105726481A (zh) 一种基于复合瓷质体的靶向线粒体纳米粒的制备及应用
MX2007001348A (es) Composiciones de vitamina b12.
CN101028281A (zh) 纳米胶体果胶铋及其颗粒剂药物
Ben Ammar et al. Graphene and Related Materials: Properties and Applications in Dentistry

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication